The US Food and Drug Administration has cleared Tyra's Investigational New Drug application to proceed with a Phase 1 clinical study of TYRA-430. The Phase 1 study will be a multicenter ...
Additional details on the meeting can be found at the WORLD Symposium website. About Spur Therapeutics Spur Therapeutics is a clinical-stage biotechnology company focused on developing life-changing ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback